Giltuss Allergy Plus Tablet
NDC Package 58552-334-20
Package Information
Giltuss Allergy Plus (chlophedianol hcl, chlorpheniramine maleate, phenylephrine hcl) tablets is usesTemporarily relieves runny nose, sneezing, and itchy and watery eyes due to hay fever or other upper respiratory allergies. This formulation utilizes a tablet delivery system. Marketed by Gil Pharmaceutical Corp, this product is identified by NDC 58552-334 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1424872 - chlophedianol HCl 24 MG / chlorpheniramine maleate 3.5 MG / phenylephrine HCl 10 MG Oral Tablet
- RxCUI: 1424872 - chlophedianol hydrochloride 24 MG / chlorpheniramine maleate 3.5 MG / phenylephrine hydrochloride 10 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58552 - Gil Pharmaceutical Corp
- 58552-334 - Giltuss Allergy Plus
- 58552-334-20 - 10 POUCH in 1 BOX / 2 TABLET in 1 POUCH
- 58552-334 - Giltuss Allergy Plus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58552-334-20 identifies a specific commercial package of 10 pouch in 1 box / 2 tablet in 1 pouch of Giltuss Allergy Plus, a human over the counter drug labeled by Gil Pharmaceutical Corp. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This tablet is formulated for oral use and contains chlophedianol hydrochloride; chlorpheniramine maleate; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Gil Pharmaceutical Corp on April 01, 2021. The current certification is valid through December 31, 2026.
How is this Gil Pharmaceutical Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58552033420. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.